The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
Other featured articles
USC Study Finds When Medicare Chips in for Hepatitis C Treatment for Medicaid Patients, Everyone Wins
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years
Applying for the 2022-2023 Roybal Center for Behavioral Interventions in Aging Pilot Projects
The Roybal Center for Behavioral Interventions in Aging seeks proposals for pilot projects that involve randomized controlled trials (RCTs).
New Schaeffer Center White Paper Explains Complicated Relationship Between FDA Approvals and Future Innovation
The relationship between approvals and future innovation is unclear at best. As such, the FDA should continue to base its decisions solely on safety and efficacy, rather than speculative long-term innovation effects.